U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342413) titled 'Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias' on Jan. 13.
Brief Summary: The primary objective is to compare physician-assessed clearance of telangiectatic veins between treatment legs using the Physician Global Aesthetic Improvement Scale (PGAIS). Secondary objectives include assessment of procedural pain, safety outcomes, and patient satisfaction.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Leg Veins
Intervention:
DRUG: Right leg treated with Glycerin compounded with 1% Lidocaine and Epinephrin...